HIGHLIGHTS
- who: Jihang Yu and collaborators from the Department of Biochemistry Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K H , Canada have published the research: COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation, in the Journal: Cells 2021, 10, x FOR PEER REVIEW of 19/08/2021
- future: Although the the authors FDA has authorized the emergency use of baricitinib in combination with remdesivir additional investigation of treatment methods is needed due to the many confounding factors. Considering that not enough studies of low . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.